Core Scientific, Inc. (CORZ) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $5.42B | Exchange | NASDAQ |
| Sector | Technology | Industry | Software - Infrastructure |
| Country | US | CEO | Adam Sullivan |
| IPO Date | 2024-01-24 | CAGR | 32.29% |
| Employees | 325 | Website | www.corescientific.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 0.52% | Total Yield | 0.52% |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $10.22B | P/E | -9.12 | Forward P/E | 138.86 | PEG | — |
| P/S | 7.2 | P/B | -1.34 | P/CF | 6.29 | P/FCF | -3.28 |
| Sales | $440.31M | Sales 1Y | 26.37% | Sales 3Y | -17.14% | Sales 5Y | — |
| EPS | $-1.85 | EPS 1Y | 333.61% | EPS 3Y | 72.63% | EPS 5Y | — |
| Sales QoQ | 42.48% | EPS QoQ | 213.21% | Sales QoQ Avg | 22.11% | EPS QoQ Avg | 178.12% |
| Gross Margin | 28.26% | Operating Margin | -224.14% | Profit Margin | -325.91% | ROCE | -39.17% |
| ROA | -27% | ROE | 99% | Altman Z Score | -1.78 | Piotroski Score | 3 |
| Current Ratio | 0.89 | Quick Ratio | 0.89 | Cash Ratio | 0.65 | Op. CF Ratio | -0.01 |
| Debt/Equity | -1.78 | Debt/Assets | 0.82 | Lt Debt/Equity | -1.78 | Lt Debt/Cap. | 2.29 |
| Intrst Cov. | -33.34 | Inventory Turnover | — | Asset Turnover | 0.08 | Receivables Turnover | — |
| Enterprise Value | $10.22B | P/E Ratio | -9.12 |
| Forward P/E | 138.86 | PEG Ratio | — |
| P/S Ratio | 7.2 | P/B Ratio | -1.34 |
| P/CF Ratio | 6.29 | P/FCF Ratio | -3.28 |
| EPS | $-1.85 | EPS Growth 1Y | 333.61% |
| EPS Growth 3Y | 72.63% | EPS Growth 5Y | — |
| Revenue Growth 1Y | 26.37% | Gross Margin | 0.28% |
| Operating Margin | -2.24% | Profit Margin | -3.26% |
| ROE | 0.99% | ROA | -0.27% |
| ROCE | -0.39% | Current Ratio | 0.89 |
| Quick Ratio | 0.89 | Cash Ratio | 0.65 |
| Debt/Equity | -1.78 | Interest Coverage | -33.34 |
| Altman Z Score | -1.78 | Piotroski Score | 3 |
Core Scientific, Inc. (CORZ) valuation & financials
Core Scientific, Inc. (CORZ) has a market capitalization of $5.42B and trades at a price-to-earnings ratio of -9.1. It operates in the Technology sector (Software - Infrastructure).
Core Scientific, Inc.'s revenue grew +26.4% over the last year.
Core Scientific, Inc.'s next earnings report is scheduled for October 23, 2026 before market open; analysts estimate EPS of $-0.01. Check the earnings calendar to see all companies reporting this week.
Core Scientific, Inc. (CORZ) — frequently asked questions
When does Core Scientific, Inc. (CORZ) report earnings next?
Core Scientific, Inc. is expected to report earnings on October 23, 2026 before market open. Analysts estimate EPS of $-0.01.
What is Core Scientific, Inc.'s market cap?
Core Scientific, Inc. (CORZ) has a market capitalization of $5.42B.
What is CORZ's P/E ratio?
Core Scientific, Inc. trades at a price-to-earnings ratio of -9.1, with trailing twelve-month EPS of $-1.85.
How fast is Core Scientific, Inc. growing?
Core Scientific, Inc.'s revenue grew +26.4% over the last year.
Compare with other Technology companies: NVIDIA (NVDA) · Apple (AAPL) · Microsoft (MSFT) · TSMC (TSM) · Broadcom (AVGO) · Samsung (005930.KS)